Skip to main content
. 2022 Jan 20;11(3):508. doi: 10.3390/jcm11030508

Table 1.

Background factors of total patients.

Total
n 175
Age (years) 66.2 ± 7.7
Sex (M/F), n 139/36
Diabetes mellitus, n (%) 24 (13.7)
Cardiovascular disease, n (%) 71 (40.5)
Drinking, n (%) 139 (79.9)
Brinkman index 606.7 ± 514.2
ASA/PS(1/2/3) 65/109/1
% FEV1 76.7 ± 7.6
% VC 100.9 ± 12.7
Weight loss rate (%) 3.2 ± 4.6
BMI (kg/m2) 21.1 ± 3.0
Alb (g/dL) 4.1 ± 0.4
PNI 49.3 ± 4.7
SGA (A/B/C) 135/24/16
NST intervention, n (%) 17 (9.7)
NAC (FP/DCF), n 122/53
Location (Ut/Mt/Lt), n 36/87/52
cStage (II/III), n 64/111
Side effect of chemotherapy
Fatigue, n (%) 14 (8.0)
Appetite loss, n (%) 17 (9.7)
Febrile neutropenia, n (%) 91 (51.9)

M: male; F: female; ASA-PS:American Society of Anesthesiologists Physical Status; FEV1.0: Forced Experiratory Volume in one second; VC: Vital Capacity; BMI: Body Mass Index; Alb: Albumin; PNI: Prognostic Nutritional Index; SGA: Subjective Global Assessment; NST: Nutritional Support Team; NAC: Neoadjuvant Chemotherapy.